Further, several factors including genetic, epigenetic, microenvironmental pathways, and metabolic pathways can all play a role in tumor dormancy and recurrence and not all of these observed in an induced Her2+/Neu model can faithfully model those seen in clinical recurrence54–56,61,73,74. The gene discussed is ERBB2; the disease is neoplasm.